Legal Pot Is More Potent Than Ever — And Still Largely Unregulated
As marijuana has become far more mainstream, potent, and sometimes dangerous, uneven regulation at the state and federal levels leaves consumers at risk.
The independent source for health policy research, polling, and news.
41-60 of 60 results
As marijuana has become far more mainstream, potent, and sometimes dangerous, uneven regulation at the state and federal levels leaves consumers at risk.
Washington state regulators found formaldehyde, lead, and arsenic in lipstick, powder foundations, skin lotions, and hair products marketed to and popular with women of color. Now legislators there are seeking to ban the products and, like at least a dozen other states, make up for lax federal rules.
Coastal and politically progressive states have passed stronger paid sick and family leave policies, but many workers in rural America are left out, facing tough decisions when choosing between caring for themselves or sick family members or keeping their jobs.
Although control of Congress was still undecided Wednesday, Republicans seemed poised to take power in the House, while the fate of the Senate remained too close to call. Economic issues were at the top of voters’ minds, but abortion access also played a large role in their decisions.
The idea of human composting — to help restore a forest or grow flowers — may be a little off-putting to some, but it has many advantages over traditional-but-toxic methods of burial and cremation.
Measures to enshrine the right to abortion in the state constitution will be on the ballot in California and Vermont this fall. Abortion-rights advocates in Michigan are hoping their state will follow suit.
Travel nurse contracts that were plentiful and paid the temporary nurses far more than hospital staff nurses are vanishing. Hospitals nationwide are turning their energies to recruiting full-time people.
Congenital syphilis rates keep climbing, according to newly released federal data. But the primary funding source for most public health departments has been largely stagnant, its purchasing power dragged even lower by inflation.
With its highest-in-the-nation vaccination rates, Vermont offers a glimpse of what’s possible as the U.S. learns to live with coronavirus.
Black Americans’ vaccination rates still trail all other groups, while Hispanics show improvement. Native Americans show the strongest rates nationally.
Covid cases have disproportionately affected the state’s Black residents, so officials are moving them to the front of the line for vaccinations before the state expands eligibility to all adults.
The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Colorado, Florida and Vermont — with the support of President Donald Trump — are exploring plans to bring drugs across the border from Canada to help lower costs.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Citing fears of losing federal funds, California is the latest state to require discharge of terminally ill residents from state veterans homes if they plan to end their lives with lethal drugs.
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Vermont embarks on a six-year experiment to redesign health care and how it’s paid for.
Proposed legislation would require drugmakers to disclose and justify price hikes. The industry has taken to Facebook and Twitter, warning that the proposal could lead to medication shortages in some regions of the state.
© 2026 KFF